U.S. flag

An official website of the United States government

NM_000053.4(ATP7B):c.3443T>C (p.Ile1148Thr) AND Inborn genetic diseases

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 24, 2015
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002453275.9

Allele description [Variation Report for NM_000053.4(ATP7B):c.3443T>C (p.Ile1148Thr)]

NM_000053.4(ATP7B):c.3443T>C (p.Ile1148Thr)

Gene:
ATP7B:ATPase copper transporting beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q14.3
Genomic location:
Preferred name:
NM_000053.4(ATP7B):c.3443T>C (p.Ile1148Thr)
HGVS:
  • NC_000013.11:g.51941194A>G
  • NG_008806.1:g.75301C>T
  • NG_008806.1:g.75301T>C
  • NM_000053.4:c.3443T>CMANE SELECT
  • NM_001005918.3:c.2822T>C
  • NM_001243182.2:c.3110T>C
  • NM_001330578.2:c.3209T>C
  • NM_001330579.2:c.3191T>C
  • NP_000044.2:p.Ile1148Thr
  • NP_000044.2:p.Ile1148Thr
  • NP_001005918.1:p.Ile941Thr
  • NP_001230111.1:p.Ile1037Thr
  • NP_001317507.1:p.Ile1070Thr
  • NP_001317508.1:p.Ile1064Thr
  • NC_000013.10:g.52515330A>G
  • NM_000053.3:c.3443T>C
  • P35670:p.Ile1148Thr
Protein change:
I1037T; ILE1148THR
Links:
UniProtKB: P35670#VAR_000768; OMIM: 606882.0021; OMIM: 606882.0025; dbSNP: rs60431989
NCBI 1000 Genomes Browser:
rs60431989
Molecular consequence:
  • NM_000053.4:c.3443T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005918.3:c.2822T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001243182.2:c.3110T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330578.2:c.3209T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330579.2:c.3191T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002614689Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Nov 24, 2015)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genotype-phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B).

Panagiotakaki E, Tzetis M, Manolaki N, Loudianos G, Papatheodorou A, Manesis E, Nousia-Arvanitakis S, Syriopoulou V, Kanavakis E.

Am J Med Genet A. 2004 Dec 1;131(2):168-73.

PubMed [citation]
PMID:
15523622

Wilson disease: high prevalence in a mountainous area of Crete.

Dedoussis GV, Genschel J, Sialvera TE, Bochow B, Manolaki N, Manios Y, Tsafantakis E, Schmidt H.

Ann Hum Genet. 2005 May;69(Pt 3):268-74.

PubMed [citation]
PMID:
15845031
See all PubMed Citations (10)

Details of each submission

From Ambry Genetics, SCV002614689.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

The p.I1148T variant (also known as c.3443T>C), located in coding exon 16 of the ATP7B gene, results from a T to C substitution at nucleotide position 3443. The isoleucine at codon 1148 is replaced by threonine, an amino acid with similar properties. In two studies, this alteration was detected in cohorts of individuals with Wilson disease (diagnoses based on clinical and biochemical symptoms) at rates of 8.7% and 9% (Mak CM, et al. J. Hum. Genet. 2008 ; 53(1):55-63, Wang LH, et al. J. Hum. Genet. 2011; 56(9):660-5). In one functional study, authors showed that this alteration did not show a loss of expression of full length protein on western blot, but they explained that the alteration is present in a b-sheet, with its functional group facing toward the nucleotide binding pocket, and may therefore affect hydrophobicity (Luoma LM, et al. Hum. Mutat. 2010;31(5):569-77). This alteration has been detected in both the heterozygous and homozygous state in several chromosomes from individuals with Wilson disease (diagnoses based on clinical and biochemical symptoms) (Gu S, et al. PLoS ONE 2013;8(7):e66526, Loudianos G, et al. Eur. J. Hum. Genet.;6(5):487-91, Dedoussis GV, et al. Ann. Hum. Genet. 2005;69(Pt 3):268-74, Panagiotakaki E, et al. Am. J. Med. Genet. A 2004;131(2):168-73, Vrabelova S, et al. Mol. Genet. Metab. ; 86(1-2):277-85, Panichareon B, et al. Eur J Med Genet ; 54(2):103-7). This variant was previously reported in the SNPDatabase as rs60431989, but was not reported in the 1000 Genomes Project or the NHLBI Exome Sequencing Project (ESP) population-based cohorts. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024